Of skin cancer and aspirin
Women who regularly use aspirin may be reducing their risk of melanoma
Regularly taking aspirin may reduce women’s risk of developing melanoma, the deadliest form of skin cancer, a study finds.
Researchers from the Stanford University School of Medicine looked at data on 60,000 American women between 50 and 79 years old over a period of 12 years, finding those who took aspirin regularly had a 21 percent lower risk of developing melanoma compared to women who did not take the anti-inflammatory, according to SFGate.com. Further, women who took aspirin for five years or more had up to a 30 percent reduction in risk.
The authors noted that the study did not meet the standards of a clinical trial, as the research involved self-reporting on the part of participants.